BlackRock’s CASI Pharmaceuticals CASI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-296
Closed -$491 5551
2025
Q3
$491 Hold
296
﹤0.01% 5366
2025
Q2
$349 Hold
296
﹤0.01% 5384
2025
Q1
$639 Hold
296
﹤0.01% 5348
2024
Q4
$838 Hold
296
﹤0.01% 5317
2024
Q3
$1.82K Hold
296
﹤0.01% 5111
2024
Q2
$1.63K Hold
296
﹤0.01% 5187
2024
Q1
$1.07K Hold
296
﹤0.01% 5202
2023
Q4
$2.12K Sell
296
-28
-9% -$135 ﹤0.01% 5239
2023
Q3
$829 Sell
324
-130
-29% -$308 ﹤0.01% 5340
2023
Q2
$1.14K Sell
454
-91,261
-100% -$245K ﹤0.01% 5398
2023
Q1
$213K Hold
91,715
﹤0.01% 4753
2022
Q4
$164K Buy
91,715
+1
+0% +$2 ﹤0.01% 4904
2022
Q3
$239K Hold
91,714
﹤0.01% 4932
2022
Q2
$263K Sell
91,714
-27,324
-23% -$119K ﹤0.01% 4965
2022
Q1
$964K Sell
119,038
-858
-0.7% -$6.74K ﹤0.01% 4675
2021
Q4
$959K Buy
119,896
+3,302
+3% +$32.9K ﹤0.01% 4681
2021
Q3
$1.39M Sell
116,594
-1,566
-1% -$21.2K ﹤0.01% 4467
2021
Q2
$1.83M Sell
118,160
-282,536
-71% -$4.75M ﹤0.01% 4309
2021
Q1
$9.62M Buy
400,696
+17,649
+5% +$496K ﹤0.01% 3595
2020
Q4
$11.3M Buy
383,047
+31,875
+9% +$693K ﹤0.01% 3299
2020
Q3
$5.37M Buy
351,172
+3,642
+1% +$68.6K ﹤0.01% 3544
2020
Q2
$8.69M Buy
347,530
+22,373
+7% +$486K ﹤0.01% 3262
2020
Q1
$6.63M Sell
325,157
-3,358
-1% -$80.1K ﹤0.01% 3214
2019
Q4
$10.2M Buy
328,515
+5,027
+2% +$163K ﹤0.01% 3245
2019
Q3
$10.8M Buy
323,488
+12,381
+4% +$397K ﹤0.01% 3167
2019
Q2
$9.96M Buy
311,107
+37,296
+14% +$1.19M ﹤0.01% 3261
2019
Q1
$7.86M Sell
273,811
-9,882
-3% -$344K ﹤0.01% 3225
2018
Q4
$11.4M Sell
283,693
-2,171
-0.8% -$82.2K ﹤0.01% 3013
2018
Q3
$13.4M Buy
285,864
+14,430
+5% +$1.01M ﹤0.01% 3088
2018
Q2
$22.3M Buy
271,434
+233,234
+611% +$15.7M ﹤0.01% 2789
2018
Q1
$1.59M Sell
38,200
-409
-1% -$15.3K ﹤0.01% 3747
2017
Q4
$1.25M Buy
38,609
+9,498
+33% +$258K ﹤0.01% 3834
2017
Q3
$515K Sell
29,111
-312
-1% -$3.64K ﹤0.01% 4055
2017
Q2
$309K Buy
29,423
+1,801
+7% +$19.1K ﹤0.01% 4143
2017
Q1
$392K Buy
+27,622
New +$375K ﹤0.01% 4031

Other funds holding CASI